A new study has found that one in five individuals taking Nirmatrelvir-ritonavir therapy, commonly known as Paxlovid, to treat severe symptoms of COVID-19, experienced a positive test result and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results